Timo Burster

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Pharmaceuticals (Basel, Switzerland)

Biomedicines

Analytical chemistry

PloS one

Nazarbayev University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nazarbayev University Jan 05 2018

Kazakhstan

Associate Professor :: Biology

University Medical Center Ulm Jul 01 2011

Germany

Privatdozent, Extraordinary Member of the University Medical Center Ulm

Ulm University Medical Centre Sep 01 2013 - Dec 31 2017

Germany

Laboratory Head

Polish Academy of Sciences Feb 01 2013 - Sep 30 2016

Poland

Visiting Professor :: Institute of Immunology and Experimental Therapy

University Medical Center Ulm Oct 01 2006 - Jun 30 2011

Germany

Team Leader

Stanford University School of Medicine Mar 01 2004 - Mar 31 2006

United States

Postdoctoral Research Fellow

University of Tübingen Jan 01 2001 - Dec 31 2003

Germany

PhD

Publications

Ruslan N Kalendar, Konstantin I Ivanov, Ilyas Akhmetollayev, Ulykbek Kairov, Olga Samuilova, Timo Burster, Andrey A Z Junior
An Improved Method and Device for Nucleic Acid Isolation Using a High-Salt Gel Electroelution Trap. Analytical chemistry (2024)
Pengfei Xu, Mike-Andrew Westhoff, Amina Hadzalic, Klaus-Michael Debatin, Lukasz Winiarski, Jozef Oleksyszyn, Christian Rainer Wirtz, Uwe Knippschild, Timo Burster
Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in Glioblastoma. ACS omega 7 (7) (2022)
Nadine Anna Schilling, Hubert Kalbacher, Timo Burster
Variation of Proteolytic Cleavage Sites towards the N-Terminal End of the S2 Subunit of the Novel SARS-CoV-2 Omicron Sublineage BA.2.12.1. Molecules (Basel, Switzerland) 27 (18) (2022)
Zhadyra Mustafa, Hubert Kalbacher, Timo Burster
Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: The amino acid substitution N679K and P681H of the spike protein. PloS one 17 (4) (2022)
Akmaral Assylbekova, Anuar Zhanapiya, Renata Grzywa, Marcin Sienczyk, Christian Schönbach, Timo Burster
Camostat Does Not Inhibit the Proteolytic Activity of Neutrophil Serine Proteases. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Timo Burster, Fabian Gärtner, Christiane Bulach, Anuar Zhanapiya, Adrian Gihring, Uwe Knippschild
Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Zhadyra Mustafa, Timo Burster
Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia. Viral immunology (2021)
Verena J Herbener, Timo Burster, Alicia Goreth, Maximilian Pruss, Hélène von Bandemer, Tim Baisch, Rahel Fitzel, Markus D Siegelin, Georg Karpel-Massler, Klaus-Michael Debatin, Mike-Andrew Westhoff, Hannah Strobel
Considering the Experimental use of Temozolomide in Glioblastoma Research. Biomedicines 8 (6) (2020)

Timo Burster.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Timo Burster